Fertility

3
Pipeline Programs
3
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

M&
Merck & Co.RAHWAY, NJ
1 program
1
EevaPhase 41 trial
Active Trials
NCT02417441Completed976Est. Feb 2017
Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
4 programs
1
1
EndometrinPhase 31 trial
Follitropin deltaPhase 11 trial
AdhesioRTN/A1 trial
Bravelle and MenopurN/A1 trial
Active Trials
NCT04840121Completed120Est. Jan 2024
NCT01669291Completed43Est. May 2014
NCT06466486Terminated310Est. Sep 2025
+1 more trials
Pfizer
PfizerNEW YORK, NY
1 program
Self administrationN/A1 trial
Active Trials
NCT00770887Completed50Est. Jun 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Merck & Co.Eeva
Ferring PharmaceuticalsEndometrin
Ferring PharmaceuticalsFollitropin delta
Ferring PharmaceuticalsAdhesioRT
Ferring PharmaceuticalsBravelle and Menopur
PfizerSelf administration

Clinical Trials (6)

Total enrollment: 2,710 patients across 6 trials

NCT02417441Merck & Co.Eeva

TiLE (Time Lapse Eeva) Clinical Trial

Start: Jun 2015Est. completion: Feb 2017976 patients
Phase 4Completed
NCT00296478Ferring PharmaceuticalsEndometrin

Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)

Start: Jul 2005Est. completion: Jul 20061,211 patients
Phase 3Completed
NCT06466486Ferring PharmaceuticalsFollitropin delta

An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation

Start: Jun 2024Est. completion: Sep 2025310 patients
Phase 1Terminated
NCT04840121Ferring PharmaceuticalsAdhesioRT

Personalizing Window of Implantation During Frozen Embryo Transfer

Start: Mar 2021Est. completion: Jan 2024120 patients
N/ACompleted
NCT01669291Ferring PharmaceuticalsBravelle and Menopur

Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation

Start: Jul 2012Est. completion: May 201443 patients
N/ACompleted
NCT00770887PfizerSelf administration

Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate

Start: May 2010Est. completion: Jun 201150 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space